Impact ledger
Regeneron Pharmaceuticals, Inc. (REGN)
5 events mapped to this ticker since 2026-06-12.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-17 | Event | Increased competitive pressure in the nephrology/rare kidney disease market, potential for reduced market share for future IgAN treatments. | Bearish | 1-5y | 0.30 |
| 2026-07-17 | Event | Potential competitive pressure in the immunology and rare disease space, influencing R&D priorities and market dynamics. | watch | 1-3m | 0.30 |
| 2026-06-23 | Event | Increased competitive threat to Dupixent (co-marketed with Sanofi), a leading treatment for atopic dermatitis and asthma. AbbVie's new assets could challenge Dupixent's market dominance in the long term. | watch | 1-3m | 0.30 |
| 2026-06-16 | Event | Potential new competitor in the wet AMD market, impacting market share and pricing power for existing treatments. | watch | 3-12m | 0.30 |
| 2026-06-12 | Event | Potential future competition in the cardiovascular/lipid-lowering market, though current impact is indirect. | watch | 3-12m | 0.30 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for REGN, start a trial or view the REGN entity page.